Palvella Therapeutics PVLA FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Palvella Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Palvella Therapeutics's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Palvella Therapeutics's FX effect on cash?
- Palvella Therapeutics (PVLA) reported FX effect on cash of -$15K in Q1 2026.
- How has Palvella Therapeutics's FX effect on cash changed year-over-year?
- Palvella Therapeutics's FX effect on cash decreased by 150.0% year-over-year, from -$6K to -$15K.
- What is the long-term trend for Palvella Therapeutics's FX effect on cash?
- Over 2 years (2021 to 2024), Palvella Therapeutics's FX effect on cash has grown at a -96.9% compound annual growth rate (CAGR), from -$3.19M to $3K.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.